TradeWorx’s Ligand Pharmaceuticals LGND Stock Holding History

TradeWorx’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-7,149	Closed	-$235K	–	447
2013 Q4	$235K	Buy	+7,149	New	+$233K	0.1%	342

Other funds holding LGND

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

DMK

David M. Knott $275M AUM 59.23% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

TradeWorx's LGND Position: Q1 2014 in Review

TradeWorx sold out of Ligand Pharmaceuticals (LGND) in Q1 2014, closing a stake of 7,149 shares — an estimated $235K sold.

TradeWorx first reported a position in LGND in Q4 2013 and held it in 1 quarter. The position peaked at $235K in Q4 2013. 184 funds tracked by Wall St. Rank hold LGND as of Q1 2014.

TradeWorx reported no remaining Ligand Pharmaceuticals position as of Q1 2014 after selling out during the quarter.
TradeWorx sold 7,149 Ligand Pharmaceuticals shares in Q1 2014, an estimated $235K.
TradeWorx first reported a position in Ligand Pharmaceuticals in Q4 2013 and held it in 1 quarter.
TradeWorx's Ligand Pharmaceuticals position peaked at $235K in Q4 2013.
184 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2014.

Based on TradeWorx's 13F filing for Q1 2014, filed 2 Jun 2014.